HomeCompareDVLN vs JNJ

DVLN vs JNJ: Dividend Comparison 2026

DVLN yields 0.06% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $269.00 in total portfolio value· pulled ahead in Year 8
10 years
DVLN
DVLN
● Live price
0.06%
Share price
$3,400.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$5.90
Full DVLN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DVLN vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDVLNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DVLN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DVLN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DVLN
Annual income on $10K today (after 15% tax)
$5.00/yr
After 10yr DRIP, annual income (after tax)
$5.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $698.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DVLN + JNJ for your $10,000?

DVLN: 50%JNJ: 50%
100% JNJ50/50100% DVLN
Portfolio after 10yr
$19.9K
Annual income
$416.84/yr
Blended yield
2.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DVLN
No analyst data
Altman Z
-1.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DVLN buys
0
JNJ buys
0
No recent congressional trades found for DVLN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDVLNJNJ
Forward yield0.06%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.8K$20.0K
Annual income after 10y$5.90$827.78
Total dividends collected$59.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DVLN vs JNJ ($10,000, DRIP)

YearDVLN PortfolioDVLN Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,706$5.88$10,676$355.77+$30.00DVLN
2$11,461$5.89$11,407$389.39+$54.00DVLN
3$12,269$5.89$12,198$426.53+$71.00DVLN
4$13,134$5.89$13,056$467.62+$78.00DVLN
5$14,059$5.89$13,987$513.12+$72.00DVLN
6$15,049$5.90$14,998$563.56+$51.00DVLN
7$16,109$5.90$16,098$619.52+$11.00DVLN
8← crossover$17,242$5.90$17,295$681.69$53.00JNJ
9$18,455$5.90$18,599$750.82$144.00JNJ
10$19,753$5.90$20,022$827.78$269.00JNJ

DVLN vs JNJ: Complete Analysis 2026

DVLNStock

DVL, Inc., together with its subsidiaries, operates as a commercial finance company in the United States. It is involved in the ownership of residual interests in securitized portfolios; ownership and development of real estate properties; ownership and servicing of a portfolio of secured commercial mortgage loans; and provision of real estate asset management and administrative services. The company was incorporated in 1977 and is based in New York, New York.

Full DVLN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DVLN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DVLN vs SCHDDVLN vs JEPIDVLN vs ODVLN vs KODVLN vs MAINDVLN vs ABBVDVLN vs MRKDVLN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.